Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Oncolytics Biotech Inc. Names Wayne Pisano As Interim CEO

PUBLIC · ONCYJun 24, 2024•almost 2 years ago

Company

Oncolytics Biotech

CalgaryBiotechnologyHealth Care

Description

Oncolytics Biotech Inc. announced that Wayne Pisano, Chair of Oncolytics' Board of Directors, will serve as the interim CEO during the medical leave of absence of Matt Coffey, PhD, President and Chief Executive Officer of Oncolytics. Mr

Company Information

Company

Oncolytics Biotech

Location

Calgary, Alberta, Canada

About

Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Oncolytics Biotech's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months